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Background: To evaluate and compare the diagnostic efficiency of serum (s) and pleural (p) levels of adenosine
deaminase (ADA)-1, ADA-2, total ADA, and interferon-gamma (IFN-γ) for the differential diagnosis of pleural
tuberculosis (TB).
Methods: Clinical and analytic data of 93 consecutive patients with pleural effusions from May 2012 to February
2013 were prospectively evaluated. The study population included 43 pleural TB, 23 malignancies, and 27 other
exudates. The median and interquartile range of ADA-1, ADA-2, total ADA, and IFN-γ were evaluated according to
their underlying diseases.
Results: There were no significant differences in sADA-1 and sIFN-γ values among each group. pADA-1, pADA-2,
total pADA, and pIFN-γ levels were significantly higher in patients with pleural TB than in other patients
(p < 0.0001). As for pleural TB receiving operating characteristic (ROC) curves identified the following results. The
best cut-off value for pADA-2 was 20.37 U/L and it yielded a sensitivity and specificity of 95.35% and 86%,
respectively. Taking a cut-off value of 40.68 U/L for total pADA, the sensitivity and the specificity were found to be
88.37% and 88%, respectively. ROC curve identified 110 U/L as the best cut-off value for pμg/ml, while the sensitivity
and the specificity were 74.42% and 68%, respectively. Finally, the best cut-off value for pADA-1 was 16.8 U/L and
yielded a sensitivity and specificity of 69.77% and 68%, respectively.
Conclusions: To distinguish pleural TB, pleural levels of ADA-2 have the highest sensitivity among the different
diagnostic parameters and may find a place as routine investigation for early detection of TB in the future.
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Pleural effusion (PE) is a very common clinical problem
and a manifestation of extrapulmonary tuberculosis (TB). It
may occur in patients affected with pulmonary TB, pneu-
monia, malignancy, congestive cardiac failure, cirrhosis of
liver, nephrotic syndrome, pulmonary infarction and con-
nective tissue disorders [1]. TB is one of the most common
causes of PE especially in the areas of high prevalence.
Diagnosis of TB pleurisy is based on observation of bacilli
in pleural fluid or granulomas in pleural biopsy specimens.
Because of the rarity of bacilli in pleural fluid, only 5% of* Correspondence: yurtsibel@hotmail.com
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unless otherwise stated.the effusions are smear positive for acid-fast bacilli and only
25% to 37% of the effusions grow Mycobacterium tubercu-
losis on the cultures [2].
Several biological markers have been proposed to en-
hance the effectiveness of the diagnosis of pleural TB. Ad-
enosine deaminase (ADA) is an enzyme involved in the
conversion of adenosine to inosine. Two isoenzymes of
ADA have been identified. They are known as ADA-1 and
ADA-2. ADA-1 is present in nearly all body cells. ADA-2 is
mainly expressed in monocytes and macrophages and is re-
leased to the extracellular space following stimulation of
these cells triggered by intracellular infection [3]. A number
of studies have analysedADA and its isoenzymes in pleural
effusions, and have found that ADA-2 isoenzyme is primar-
ily responsible for the total ADA activity in tuberculous. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pneumonic effusions [2,3]. Equally, the highest ADA activ-
ity was found in lymphocytes and monocytes. ADA-2 could
be detected only in monocytes and serum ADA most prob-
ably originated from lymphocyte precursors. Valdes et al.
demonstrated that the activity of both isoenzymes contrib-
utes to the high ADA activity in pleural TB, with ADA-2
playing the predominant role [4]. Elevated ADA activity
is not specific for pleural TB, but is also seen in para-
pneumonic effusions and pleural empyemas, rheuma-
toid effusions, and certain malignant pleural effusions.
Another highly sensitive and specific marker of the pleural
TB is interferon-gamma (IFN-γ) [5]. The increased IFN-γ
concentration in TB can be explained by the cellular mech-
anisms of immune reactions to infection with M. tubercu-
losis. Expression of M. tuberculosis antigens on the surface
of antigen-presenting cells leads to T cell activation, in-
creased T cell count, and release of cytokines that play a
role in the further stages of the immune response [6].
The aim of the present study was to evaluate and com-
pare the diagnostic efficiency of serum (s) and pleural
(p) levels of ADA-1, ADA-2, total ADA, and IFN-γ for
the differential diagnosis of pleural TB.
Methods
Study design
The study was approved by the Ethical Committee of the
Yedikule Chest Disease and Chest Surgery Education and
Research Hospital. Written informed consent was obtained
from all subjects. Clinical and analytic data of 93 consecu-
tive patients, admitted to our tertiary center with pleural
effusions and diagnosed by analysis of fluid samples ob-
tained by thoracentesis or chest drainage from May2012 to
February 2013, was prospectively evaluated.
All patients provided a medical history, and underwent
detailed physical examination and routine laboratory tests.
Flexible bronchoscopy, computed tomography of the chest,
and echocardiogram were performed when indicated.
Pleural effusions were defined as exudates when the ana-
lysis indicated that the fluid satisfied the criteria of Light
et al. [7]. Cytological and microbiological examinations of
pleural fluid were performed. All tuberculosis patients were
diagnosed with pleural biopsy. Pleural effusions were diag-
nosed as malignant when fluid cytology or pleural biopsy
findings were positive for malignancy. All other exudative
effusions were included in the miscellaneous group. The
patients who had not met the above mentioned diagnostic
criteria for pleural effusion and also those who had been di-
agnosed with the heart failure, kidney failure, liver cirrhosis,
and HIV infection, those on TB treatment, those with em-
pyemas, and those with nephrotic syndrome and transudate
were not included in the study. Furthermore, patients af-
fected with pleural effusions of unknown etiology were ex-
cluded from the study.The median and interquartile range of ADA-1, ADA-
2, total ADA, and IFN-γ levels in the serum and PE were
evaluated according to their underlying diseases for the
diagnostic accuracy.
Measurement of serum and pleural adenosine deaminase
levels
ADA activity in the pleural fluid was determined with De
Giusti’s method and the results were recorded as IU/L in all
the patients [8]. A blood sample was taken from the ante-
cubital vein, which was then centrifuged at 3000xg for
10 min. within half an hour and stored at −20°C until assay.
The manual kinetic ADA activity assay was optimized for
the automated analyzer (Konelab 60 I, Thermo Labsystems
CLD, Espoo, Finland). For the determination of ADA activ-
ity, the ammonia produced by the enzymatic activity was
coupled to 2-oxoglutarate by glutamate dehydrogenase. 2-
oxoglutarate was activated by adenosine diphosphate
(ADP). In this reaction, NADH was used as indicator and
the reaction was followed by the decrease of absorbance at
340 nm, according to method developed by Ellis [9]. To
distinguish ADA-1 from ADA-2, the activity was measured
using the same techniques with Erythro-9 (2-hydroxy-3-
nonyl) adenine (EHNA) which is a potent inhibitor of only
ADA-1 isoenzyme, showing the ADA-2 activity. The activ-
ity of ADA-1 was calculated by subtracting the ADA-2 ac-
tivity from total ADA activity.
Measurement of serum and pleural interferon-γ levels
The second generation QuantiFERON® TB-Gold test
(Cellestis®, Carnagie Australia) measures in vitro IFN-γ
production originating from immune T-cells during
in vitro stimulation with peptides of the M. tuberculosis
specific antigens [10,11]. One ml of blood sample or
1 ml of pleural fluid mononuclear cells isolated from
pleural fluid by density gradient centrifugation was
added to QuantiFERON®-TB Gold (QFT-TB) tubes. The
tubes were centrifuged and 500 μl of the supernatants
were harvested and stored at −70°C until the IFN-γ was
measured in an ELISA reader. The μg/ml concentrations
(IU/ml) were calculated by the ‘QFT-TB analysis
Software’.
Statistical analyses
Data were analysed using the Statistical Package for Social
Sciences (SPSS) software version 19.0 (SPSS Inc., Chicago,
IL) and Medcalc (Mariakerke, Belgium) for Windows. A
normal distribution of the quantitative data was checked
using Kolmogorov-Smirnov test. Parametric tests were ap-
plied to data of normal distribution and non-parametric
tests were applied to data of questionably normal distribu-
tion. Mann–Whiney U-test was used to compare two inde-
pendent groups. The Kruskal–Wallis analysis of variance
test was used to compare groups and the Bonferroni-
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servative measure of significance for multiple comparisons.
Receiver operating characteristic (ROC) curves were used
to identify the optimal cut-off points. The distribution of
categorical variables in both groups was compared using
Pearson chi-square test. Data were expressed as median
(interquartile range). Categorical variables were expressed
as frequencies and percentages. Statistical significance was
assumed for p < 0.05.Results
The study population included 63 men and 30 women.
According to clinical diagnosis, the study population (93
patients) was distributed into the three groups as fol-
lows: 43 patients with pleural TB confirmed by culture
and/or compatible pleural biopsy specimen (none of
them was on treatment), 23 patients with malignancy,
and 27 patients with benign nontuberculous effusion
(pleural effusion due to an etiology other than TB or
malignancy). Within the group with another etiology, 27
patients had pleural effusions associated with bacterial
pneumonia or nonspecific pleural effusion, pulmonary
embolism, parapneumonic effusions. Age and gender
characteristics of pleural and serum groups were pre-
sented in Tables 1 and 2. Groups did not differ from
each other with respect to smoking habits neither in the
pleural measurements group (p = 0.267), nor in the
serum measurements group (p = 0.427).Table 1 Pleural adenosine deaminase and interferon-γ levels





Age (yrs) 26 (20–35) 62 (49–75)
Male/female 30/13 12/11
Pleural ADA-1 (U/L) 21.06 (14.55-33.56) 7.48 (5.61-17.16)
Pleural ADA-2 (U/L) 38.00 (29.66-53.15) 8.86 (6.40-12.60)
Pleural total ADA (U/L) 60.04 (44.66-87.60) 19.78 (16.02-24.43
Pleural μg/ml (pg/ml) 185.00 (105.00-460.00) 55.00 (15.00-110.0
ADA, Adenosine deaminase; IFN-γ, Interferon gamma.
Data are expressed as median (interquartile range).Comparative characteristics of pleural adenosine de-
aminase and pleural interferon-γ levels measurements
among patients with tuberculosis, with malignancy and
with benign non-tuberculosis pleural effusions are pre-
sented in Table 1. Serum measurements group included
43 patients with pleural TB, 23 patients with malignant
effusions and 27 with benign non-tuberculosis effusions.
pADA-1, pADA-2, total pADA, and pIFN-γ levels were
significantly higher in patients with pleural TB than in
other patients (p < 0.0001).
Comparative characteristics of serum adenosine deam-
inase, pleural interferon-γ levels among patients with tu-
berculosis, patients with malignancy and patients with
benign non-tuberculosis effusions are presented in
Table 2. Serum measurements group included 23 pa-
tients with pleural TB, 11 patients with malignant
pleural effusion, and 18 patients with benign non-
tuberculosis effusions. There were no significant differ-
ences in sADA-1 and sIFN-γ values among. sADA-2 and
total sADA levels significantly differed between patients
with pleural TB and those with benign non-tuberculosis
effusions (p = 0.001, and p = 0.004, respectively).
As for pleural TB receiving operating characteristic
(ROC) curves identified the following results (Table 3)
(Figures 1 and 2). The best cut-off value for pADA-2
was 20.37 U/L and yielded a sensitivity and specificity of
95.35% and 86%, respectively. Taking a cut-off value of
40.68 U/L for total pADA, the sensitivity and the specifi-
city were found to be 88.37% and 88%, respectively.in patients with tuberculosis, malignancy and
ancy) Group 3 (Non-tuberculosis
non-malignancy) (n = 27)
p
67 (44–75) 0.0001 P (1–2) = 0.0001
P (1–3) = 0.0001
P (2–3) = 0.907
21/6 0.144
14.89 (7.39-21.06) 0.0001 P (1–2) = 0.0001
P (1–3) = 0.008
P (2–3) = 0.067
11.32 (5.80-15.23) 0.0001 P (1–2) = 0.0001
P(1–3) = 0.0001
P(2–3) = 0.402
) 23.92 (16.36-40.11) 0.0001 P (1–2) = 0.0001
P (1–3) = 0.0001
P (2–3) = 0.170
0) 75.00 (36.00-195.00) 0.0001 P (1–2) = 0.0001
P (1–3) = 0.006
P (2–3) = 0.110
Table 2 Serum adenosine deaminase and interferon-γ levels in patients with tuberculosis, malignancy and






non-malignancy) (n = 18)
p Value
Age (yrs) 25 (20–37) 65 (50–68) 67.5 (45–75) 0.0001 P (1–2) = 0.0001
P (1–3) = 0.0001
P (2–3) = 0.946
Male/female 15/8 7/4 15/3 0.368
Serum ADA-1 (U/L) 11.32 (4.43-18.01) 11.52 (8.64-16.24) 10.81 (6.70-14.89) 0.983
Serum ADA-2 (U/L) 16.54 (12.11-20.77) 11.36 (7.16-20.00) 10.00 (6.59-13.00) 0.004 P (1–2) = 0.068
P (1–3) = 0.001
P (2–3) = 0.393
Serum total ADA (U/L) 28.98 (24.51-33.66) 27.39 (15.68-35.14) 21.70 (17.73-27.05) 0.034 P (1–2) = 0.473
P (1–3) = 0.004
P (2–3) = 0.605
Serum μg/ml (pg/ml) 75.00 (35.00-160.00) 50.00 (15.00-90.00) 57.50 (30.00-115.00) 0.513
ADA, Adenosine deaminase; IFN-γ, Interferon gamma.
Data are expressed as median (interquartile range).
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for pIFN-γ, while the sensitivity and the specificity were
found to be 74.42% and 68%, respectively. Finally, the
best cut-off value for pADA-1 was 16.8 U/L and yielded
a sensitivity and specificity of 69.77% and 68%,
respectively.
For pleural TB cases, the area under the curve (AUC)
of the ROC curve was highest for pADA-2 (0.936 ±
0.027), followed by total pADA (0.925 ± 0.029), pIFN-γ
(0.759 ± 0.051), sADA-2 (0.759 ± 0.069), and pADA-1
(0.750 ± 0.051) (Table 3).
Discussion
Conventional methods to diagnose pleural TB have
proven to be insufficient. Every test that could increase
the confidence of resuming or discontinuing antituber-
culosis therapy is of clinical relevance, especially in en-
demic areas of the world. Thus, there is a need to
develop a diagnostic marker that can offer a rapid andTable 3 Pleural and serum adenosine deaminase and interfer
of pleural tuberculosis
Cut-off (U/L) Sensitivity (%) Specific
Pleural ADA-1 >16.8 69.77 68
Pleural ADA-2 >20.37 95.35 86
Pleural total ADA >40.68 88.37 88
Pleural IFN-γ >110 74.42 68
Serum ADA-1 ≤5.34 34.78 89.66
Serum ADA-2 >13.64 69.57 75.86
Serum total ADA >23.07 86.96 55.17
Serum IFN-γ >70 56.52 68.97
ADA, Adenosine deaminase; AUC, Area under the curve; IFN-γ, Interferon gamma; Naccurate diagnosis. The quantification of IFN-γ and the
measurement of ADA have shown high sensitivity and
specificity in pleural TB, especially in the areas of high
prevalence [12,13]. In this study, we aimed to evaluate
and compare the diagnostic efficiency of serum and
pleural levels of ADA-1, ADA-2, total ADA, and IFN-γ
for the differential diagnosis of pleural TB.
The sensitivity and robustness of ADA activity in the
diagnosis of pleural TB, together with its simplicity,
speed, and low cost, urge the widespread implementa-
tion and routine utilization of the method. However, the
cause of increased ADA activity in pleural TB is still un-
certain. The suggestion that it is related to increased
lymphocyte counts in these effusions appears to have
been ruled out by several studies [14,15]. The finding
that increased ADA activity in tuberculous pleurisy is
due largely to increased activity of the ADA isoenzyme
ADA-2, together with the fact that the only cells in
which ADA-2 has been found are monocytes/on-γ levels evaluated for the diagnostic accuracy
ity (%) PPV (%) NPV (%) AUC ± Sh p Value
65.2 72.3 0.750 ± 0.051 0.0001
85.4 95.6 0.936 ± 0.027 0.0001
86.4 89.8 0.925 ± 0.029 0.0001
66.7 75.6 0.759 ± 0.051 0.0001
72.7 63.4 0.515 ± 0.081 0.8536
69.6 75.9 0.759 ± 0.069 0.0002
60.6 84.2 0.694 ± 0.074 0.0095
59.1 66.7 0.567 ± 0.081 0.4096
PV, Negative predictive value; PPV, Positive predictive value.
Figure 1 Receiver operating characteristic (ROC) curves showing the sensitivity and specificity presented in Table 1 at various cut-off
values for adenosine deaminase-1, adenosine deaminase-2, total adenosine deaminase, and interferon-gamma in pleural fluid.
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activity in pleural TB to the stimulation of monocytes/
macrophages by live phagocytosed micro-organisms
[16]. The unique origin of ADA-2 has been confirmed
by Ungereret al., who revealed that the increased ADA
activity in pleural TB is due largely to increased ADA-2
activity [17].
A meta-analysis of 31 studies published between 1978
and 2000, which assessed the value of pleural fluid ADA ac-
tivity in differential diagnosis of pleural TB demonstrated a
high sensitivity and specificity of these measurements (92
and 89%, respectively) [18]. In the most recent meta-
analysis of studies investigating the use of pleural fluid
ADA activity for the diagnostic evaluation of pleural TB, in
which a total of 63 studies have been analyzed, sensitivity
was estimated at 92% and specificity at 90% [19]. Similar to
our study, in over 2/3 of these studies ADA activity was
measured with a colorimetric method described by Gusti
[8]. However, Zaricet al.found that the diagnostic sensitivity
of ADA determination in tuberculous pleural effusion was
89.2%, but the specificity was only 70.4% [20]. One reason
for this discrepancy may be the differences in the method-
ology of ADA activity measurements. Although the cut-off
value applied by different authors ranged between 10 and
70 U/L, the mean total pADA cut-off value in 31 analyzed
studies was very close to the best discriminating value in
our study (41.8 and 40.68 U/L, respectively).Two molecular forms of ADA, each with its own
unique properties, have been identified in humans:
ADA-1 and ADA-2 [21]. Each isoform is coded for by a
different gene locus [17]. ADA-1 has the highest activity
in lymphocytes and monocytes, whereas ADA-2 appears
to be originated from monocytes [22]. Ungerer and Gro-
bler identified ADA-2 and ADA-1 in pleural fluid, with
ADA-2 being predominant in TB [23]. The latter finding
was confirmed by Kurataet al. [20]. Ungereret al. re-
peated their results, and showed that parainfective effu-
sions were associated with ADA-1, while tuberculous
effusions were associated with the ADA-2 isoenzyme
[24]. With a cut-off level of 20.37 U/L estimated from
pADA-2 ROC analysis, we found relatively high diagnos-
tic sensitivity and specificity of the test (95.35 and 86%),
respectively.
IFN-γ proved to be highly associated with tuberculous
etiology of pleural effusion [5]. Redistribution of T and B
cells and the stimulation of T cells present in the pleural
cavity explain the differences between the concentration
of IFN-γ in pleural fluid and peripheral blood. One of
the studies demonstrated that median IFN-γ concentra-
tion in pleural effusion was over 60 times higher than
that in the blood [25]. However, in our study, in patients
with TB, pleural IFN-γ concentration was only 2.4 times
greater than the serum concentration. The sensitivity
and specificity of IFN-γ measurements as a diagnostic
Figure 2 Receiver operating characteristic (ROC) curves showing the sensitivity and specificity at various cut-off values for adenosine
deaminase-1, adenosine deaminase-2, total adenosine deaminase, and interferon-gamma in serum.
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from 95 to 97%, respectively [12,26]. The methodology
of IFN-γ determination used in most of the studies was
similar and based on using commercial immunoenzy-
matic assays (ELISA). In 2007, a meta-analysis which
summarized the results of 22 studies evaluating the use-
fulness of IFN-γ determination for the diagnosis of TPE
was published [12]. In this meta-analysis, the mean sen-
sitivity was 89%, while the mean specificity was 97%.
However, in our study, we obtained very low sensitivity
and specificity percentages when compared to the litera-
ture. As for pleural IFN-γ levels, by setting the cut-off
value for pIFN-γ concentration at 110 U/L we obtained
diagnostic sensitivity of 74.42%, specificity of 68%, nega-
tive predictive value of 75.6%, and positive predictive
value of 66.7%. As for serum IFN-γ levels, by setting the
cut-off value for pμg/ml concentration at 70 U/L we ob-
tained diagnostic sensitivity of 56.52%, specificity of
68.97%, negative predictive value of 66.7%, and positive
predictive value of 59.1%. The main reason for the low
sensitivity and specificity determined in our study is
thought to be due to the small sample size.
ADA and IFN-γ measurements are simple and have the
advantage of being a rapid and direct means of detecting
M. tuberculosis in pleural fluid, whereas PCR is a more de-
manding and expensive method . Limitations of our studyare the relatively small size of our series and lack of definite
criteria for selection of patients for this method. However,
we hope that this study will pioneer further studies for the
non-invasive differential diagnosis of pleural TB.Conclusions
In conclusion, pleural ADA-2 and total ADA activities
are sensitive and specific markers of pleural TB. In dis-
tinguishing pleural TB, pleural levels of ADA-2 have the
highest sensitivity among the different diagnostic param-
eters and may find a place as a routine investigation in
the coming days for early detection of TB. Although
these tests may reduce the number of patients referred
to more invasive diagnostic procedures, they should not
be considered an alternative to biopsy and culture. Cul-
tures of pleural fluid and biopsy specimens have a
greater diagnostic yield.
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